169 related articles for article (PubMed ID: 7611200)
21. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
[TBL] [Abstract][Full Text] [Related]
22. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
23. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms.
Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K
Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349
[TBL] [Abstract][Full Text] [Related]
25. [Screening for colorectal cancer with an immunological fecal occult blood test].
Fernández JL; Gallegos M; Brochero A; Arévalo C; Piccioni H; Gutiérrez Galiana H
Acta Gastroenterol Latinoam; 1999; 29(2):73-8. PubMed ID: 10491719
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
27. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study.
Rozen P; Knaani J; Samuel Z
Cancer; 2000 Jul; 89(1):46-52. PubMed ID: 10896999
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
[TBL] [Abstract][Full Text] [Related]
30. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
31. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
Nakama H; Zhang B; Kamijo N
Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
[TBL] [Abstract][Full Text] [Related]
34. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W
Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374
[TBL] [Abstract][Full Text] [Related]
35. The first 2 years of colorectal cancer screening in Ferrara, Italy.
Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
[TBL] [Abstract][Full Text] [Related]
36. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
Macrae FA; St John DJ
Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of immunochemical and biochemical methods for determination of occult fecal blood].
Ferkl M; Kocna P; Fric P
Cas Lek Cesk; 1992 Mar; 131(5):149-51. PubMed ID: 1581946
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
[TBL] [Abstract][Full Text] [Related]
39. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.
Rozen P; Waked A; Vilkin A; Levi Z; Niv Y
Med Sci Monit; 2006 Jun; 12(6):MT27-32. PubMed ID: 16733493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
